Endometrial Cancer Trial, Recruiting NCT05092022 Sponsor: Milton S. Hershey Medical Center Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT05092022
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are due or overdue for cervical cancer screening but have not had it done recently
  • People who can speak, read, and communicate well in English or Spanish
  • People who are not considered to be at higher-than-average risk for cervical cancer

Who may not be able to join:

  • People who are currently pregnant
  • People who are currently incarcerated
  • People who are at higher-than-average risk for cervical cancer, such as those who have already been diagnosed with high-grade precancerous cervical changes, or those who have a weakened immune system
  • People who are not able to speak, read, and communicate well in English or Spanish
  • People who are unable or unwilling to give consent or complete what the study requires

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christina Scartozzi, DO, Penn State College of Medicine

Phone: 610-208-4610

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Milton S. Hershey Medical Center
Registry
ClinicalTrials.gov
Start date
18 September 2023
Est. completion
31 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of patients who request the self-sampled HPV test; Number of patients who request the clinician-sampled test; Number of patients who complete the self-sampled HPV test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov